Dr Donovan C Polack, MD | |
11155 Dunn Rd, Suite 211n, Saint Louis, MO 63136-6150 | |
(314) 741-1600 | |
(314) 741-1677 |
Full Name | Dr Donovan C Polack |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 45 Years |
Location | 11155 Dunn Rd, Saint Louis, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659324465 | NPI | - | NPPES |
202546321 | Medicaid | MO | |
036072078 | Medicaid | IL |
Facility Name | Location | Facility Type |
---|---|---|
Metro Dialysis Center - North | Florissant, MO | Dialysis facility |
St. Louis Regional Dialysis Center, Inc. | Saint ann, MO | Dialysis facility |
Davita - Granite City Dialysis Center | Granite city, IL | Dialysis facility |
Fresenius Of Normandy | Normandy, MO | Dialysis facility |
Christian Hospital Northeast | Saint louis, MO | Hospital |
Ssm Depaul Health Center | Bridgeton, MO | Hospital |
Gateway Regional Medical Center | Granite city, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Louis Kidney Care Llc | 6305130667 | 7 |
St Louis Kidney Care Llc | 6305130667 | 7 |
News Archive
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is often diagnosed at a late stage, when curative treatment is no longer possible. A team led by investigators at Beth Israel Deaconess Medical Center has now identified and validated an accurate 5-gene classifier for discriminating early pancreatic cancer from non-malignant tissue.
Regular gamblers were more than six times more likely to gamble online compared to before the COVID-19 pandemic, according to new research.
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways.
› Verified 7 days ago
Entity Name | Metro Hypertension & Kidney Center Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386688646 PECOS PAC ID: 3375500283 Enrollment ID: O20041213000516 |
News Archive
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is often diagnosed at a late stage, when curative treatment is no longer possible. A team led by investigators at Beth Israel Deaconess Medical Center has now identified and validated an accurate 5-gene classifier for discriminating early pancreatic cancer from non-malignant tissue.
Regular gamblers were more than six times more likely to gamble online compared to before the COVID-19 pandemic, according to new research.
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways.
› Verified 7 days ago
Entity Name | St Louis Kidney Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780058727 PECOS PAC ID: 6305130667 Enrollment ID: O20160809001801 |
News Archive
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is often diagnosed at a late stage, when curative treatment is no longer possible. A team led by investigators at Beth Israel Deaconess Medical Center has now identified and validated an accurate 5-gene classifier for discriminating early pancreatic cancer from non-malignant tissue.
Regular gamblers were more than six times more likely to gamble online compared to before the COVID-19 pandemic, according to new research.
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Donovan C Polack, MD 11155 Dunn Rd Ste 211n, Saint Louis, MO 63136-6166 Ph: (314) 741-1600 | Dr Donovan C Polack, MD 11155 Dunn Rd, Suite 211n, Saint Louis, MO 63136-6150 Ph: (314) 741-1600 |
News Archive
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is often diagnosed at a late stage, when curative treatment is no longer possible. A team led by investigators at Beth Israel Deaconess Medical Center has now identified and validated an accurate 5-gene classifier for discriminating early pancreatic cancer from non-malignant tissue.
Regular gamblers were more than six times more likely to gamble online compared to before the COVID-19 pandemic, according to new research.
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways.
› Verified 7 days ago
Dr. Isik Turker, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Nephrology Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |